MNOV · NASDAQ
MediciNova (MNOV) Stock Price & Fundamentals
MediciNova (MNOV) closed at $407.57 on Oct 9, 2026, down 0.30% from the previous close of $408.81.
Share price, past year
1Y +38.71%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $407.57 |
| Sep 30, 2026 | $403.80 |
| Aug 31, 2026 | $390.29 |
| Jul 31, 2026 | $367.16 |
| Jun 30, 2026 | $356.41 |
| May 29, 2026 | $340.17 |
| Apr 30, 2026 | $337.94 |
| Mar 31, 2026 | $322.64 |
| Feb 27, 2026 | $321.74 |
| Jan 30, 2026 | $344.75 |
| Dec 31, 2025 | $310.13 |
| Nov 28, 2025 | $304.50 |
| Oct 31, 2025 | $295.73 |
Key statistics
- Market cap
- $20.06B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.21
- Revenue (TTM)
- —
- Net income (TTM)
- −$10.75M
- Shares outstanding
- 49.2M
- Dividend yield
- —
- 52-week range
- $290.76 – $411.36
MediciNova's market cap is $20.06B, based on a share price of $407.57 and 49.2M shares outstanding as of Jun 30, 2026.
Financials
MediciNova reported revenue of $409.66K for fiscal 2025.
MediciNova reported a net loss of $12.00M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $409.66K | −59.0% | −$12.00M | −2,928.8% | −$0.24 | −$9.81M |
| FY2023ended Dec 31, 2023 | $1.00M | −75.2% | −$8.57M | −857.2% | −$0.17 | −$7.45M |
| FY2021ended Dec 31, 2021 | $4.04M | +123,863.8% | −$10.13M | −251.0% | −$0.21 | −$9.41M |
| FY2013ended Dec 31, 2013 | $3.26K | −99.6% | — | — | — | −$10.69M |
| FY2012ended Dec 31, 2012 | $802.58K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $458.44K | −$2.31M | −$0.05 |
| Q1 FY2026ended Mar 31, 2026 | $186.98K | −$2.59M | −$0.05 |
| Q3 FY2025ended Sep 30, 2025 | $123.32K | −$3.05M | −$0.06 |
| Q2 FY2025ended Jun 30, 2025 | $134.60K | −$3.28M | −$0.07 |
| Q3 FY2023ended Sep 30, 2023 | $1.00M | — | — |
| Q3 FY2021ended Sep 30, 2021 | $37.50K | — | — |
| Q1 FY2021ended Mar 31, 2021 | $4.00M | — | — |
| Q1 FY2015ended Mar 31, 2015 | $0.00 | — | — |
Company profile
- Name
- MediciNova, Inc.
- Ticker
- MNOV
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 4275 Executive Square, Suite 300, La Jolla, CA 92037
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001226616
Recent SEC filings
- Sep 28, 2026
- Sep 2, 2026
- Aug 19, 2026
- Aug 13, 2026
- Jun 24, 2026
- May 14, 2026
- Mar 10, 2026
- Feb 20, 2026
Frequently asked questions
What is MediciNova's stock price?
MediciNova (MNOV) closed at $407.57 on Oct 9, 2026, down 0.30% from the previous close of $408.81.
What is MediciNova's market cap?
MediciNova's market cap is $20.06B, based on a share price of $407.57 and 49.2M shares outstanding as of Jun 30, 2026.
How much revenue does MediciNova make?
MediciNova reported revenue of $409.66K for fiscal 2025.
Does MediciNova pay a dividend?
MediciNova's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from MediciNova, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures